Cat.#: ACPP-1327
| Despition | Dopamine Receptor D1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1317 | Noelin Blocking Peptide (AC1317) | 250 µg | inquiry |
| ACPP-1429 | Human FGF14 Protein (AC1429) | 2 µg | inquiry |
| ACPP-1148 | Recombinant Human NCAM1 Protein (Fc Tag) (AC1148) | 50 µg | inquiry |
| ACPP-1027 | Recombinant Human Ephrin A3 Protein (Fc Tag) (AC1027) | 50 µg | inquiry |
| ACPP-1025 | Recombinant Human GPR56 Protein (6×His Tag) (AC1025) | 50 µg | inquiry |
| ACPP-1180 | Native Human Luteinizing Hormone (Functional) (AC1180) | 100 µg | inquiry |
| ACPP-1249 | TMPRSS2 Blocking Peptide (AC1249) | 250 µg | inquiry |
| ACPP-1376 | Mouse S100A5 Protein (AC1376) | 5 µg | inquiry |
| ACPP-1459 | Human Midkine Protein, His (AC1459) | 5 µg | inquiry |
| ACPP-1424 | Human IMPA2 Protein (AC1424) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.